Immunology

Immune responses to COVID-19

Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a new study.

June: Science news in numbers

A breakdown of science news this month, in numbers.

War on cancer: to screen or not to screen?

Steve Clarke on the history of screening tests and programme criteria, as applied to cancer screening, notably colorectal cancer.

In search of a vaccine

We look at the frontline of vaccine development and how and when immunity to COVID-19 may be a possibility.

"Childhood vaccines enhance cancer treatment"

Scientists claim new research shows that pre-immunisation, acquired through common childhood vaccines, can be used to enhance therapeutic cancer treatment.

January news in numbers

A breakdown of science news this month, in numbers.

My lab: specialised transplantation testing

Healthcare Scientist Liam Oates gives a guided tour of the Welsh Transplantation and Immunogenetics Laboratory.

The jumping gene and the soluble protein

Kevin Ng and colleagues are behind the discovery of a soluble protein produced by a “jumping gene” – an insertion of ancient parasitic DNA into the genome. The work has the potential to transform immunotherapy treatment and may also have therapeutic implications.

Tackling drug-resistant strains of TB

New drugs to treat strains of TB that have become resistant to treatment are now a possibility it is claimed, following a discovery from the University of Surrey.

Anaphylaxis: a personal account

Have you ever associated food with fatality? Have you ever felt anxious, as if you could be eating your Last Supper? Oli Weatherall has.

HIV “reservoir” finding

Antiretroviral therapy (ART) can suppress HIV to the point where the virus is nearly undetectable, and people on medication can live for many years. 

Top